Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced nonsmall cell lung cancer.

Emanuele VitaFederico MonacaDomenico MilardiLuca MastrantoniAlessio StefaniEdoardo VerganiJacopo RussoDiletta BaroneIleana SparagnaAntonio VitaleAlessandro ScalaDenis OcchipintiMariantonietta Di SalvatoreAlfredo PontecorviGiampaolo TortoraEmilio Bria

Published in: Cancer (2024)

Symptoms of androgen deficiency should be tracked in male patients with ALK-positive ANSCLC who are receiving alectinib, and testosterone replacement should be considered, as appropriate.

Keyphrases

replacement therapy
advanced non small cell lung cancer
epidermal growth factor receptor
single cell
cell therapy
mental health
smoking cessation
mesenchymal stem cells
depressive symptoms
physical activity